A Delaware district court is hearing arguments this week in French drug giant Sanofi-Aventis’ trademark infringement lawsuit against upstart Advancis Pharmaceutical Corp.
Amid strong growth in intellectual property practices at general-practice firms, many firms are looking to Baker Botts as a model for how to grow aggressively through acquisitions and lateral hiring.
With a fondness for folksy adages, a focus on old fashioned teamwork and a healthy respect for the value of blowing off a little steam, Skadden sounds more like a scrappy upstart practice than the 1,700 attorney mega-firm it is.
Newly merged Pillsbury Winthrop Shaw Pittman LLP has tapped William Atkins and Larry Gotts to head up the firm’s combined intellectual property department.
Industry representatives praised plans for sweeping reforms of the U.S. patent system at a hearing held Wednesday in the U.S. House of Representatives.
In a stinging rebuke to companies that try to divorce themselves from patent infringement liability, a bankruptcy judge in Atlanta has ordered Weyerhaeuser Co. to pay $458 million to a spin-off that inadvertently took over a diaper that infringed patents held by a rival.
Johnson & Johnson is emerging triumphantly from its patent litigation against its rivals in the highly lucrative market for drug-eluting stents, winning a second major victory this month in a jury verdict that could lead to hundreds of millions of dollars in damages.
William B. Marianes, who chaired Troutman Sanders’ intellectual property practice group for 15 years, has left the firm to join McGuireWoods LLP as a partner in Atlanta.
Akamai Technologies has acquired rival Speedera Networks for $130 million in a deal that resolves the two companies’ bitterly fought patent and trade-secrets litigation, which had reportedly become prohibitively expensive.
Fresh off its loss against rival Guidant in a patent dispute over drug-coated stents, medical device maker Medtronic said Monday it has lost another dispute against Johnson & Johnson Inc.’s Cordis Corp. in a Delaware jury retrial.
In a decision that could lead to damages of up to hundreds of millions of dollars, a federal jury in Delaware has found that medical device maker Medtronic Inc. infringed rival Guidant Corp.'s patents for drug-coated stents.
Medical device maker Conor Medsystems Inc. has filed a lawsuit against Angiotech Pharmaceuticals Inc. in a U.K. court, seeking the revocation of a patent for stents coated with paclitaxel and a polymeric carrier.
The proposed merger between Pillsbury Winthrop LLP and Shaw Pittman LLP will create one of the largest intellectual property groups in the U.S. and give the combined firms a dominating position among general-practice firms in the Washington, DC area.
Brown Raysman has hired the former head of Coudert Brothers’ intellectual property department for its Los Angeles office.
Fabio E. Marino, a partner in Bingham McCutchen LLP’s Silicon Valley office, has been named to head the firm’s IP litigation and patent prosecution group with Bob Schroeder and Mary Huser.
Kirkpatrick & Lockhart Nicholson Graham has hired five partners for its Boston intellectual property practice from Testa, Hurwitz & Thibeault, LLP, as local firms continue to hire opportunistically following the collapse of the Boston technology firm.
Canada’s Angiotech Pharmaceuticals Inc. and its corporate partner, Boston Scientific Corp., have filed a patent infringement lawsuit against Conor Medsystems Inc. in Dutch courts in an effort to stop the rival from commercializing its paclitaxel-coated stent.
The European Patent Office has upheld the validity of Canadian medical device maker Angiotech Pharmaceuticals’ patent on specially coated medical stents, the company said Monday.
Davis Wright Tremaine LLP has hired two patent attorneys from Pillsbury Winthrop for its Los Angeles office.
Goodwin Procter has hired 24 partners from soon-to-disband Testa, Hurwitz & Thibeault and McDermott, Will & Emery, including many of Testa Hurwitz’ top IP attorneys.